Randomized Controlled Trial of Genomically Directed Therapy in Patients With Triple Negative Breast Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Malignant Neoplasm of Breast|Breast Cancer
Interventions: DRUG: Genomically Directed Monotherapy|OTHER: Observation/Standard Therapy
Sponsor: Bryan Schneider, MD
Collaborators: Hoosier Cancer Research Network|Vera Bradley Foundation for Breast Cancer|Walther Cancer Institute|Strategic Research Initiative Grant through IUSCC